[Skip to Content]
[Skip to Content Landing]
Citations 0
November 18, 2009

Complications Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures—Reply

JAMA. 2009;302(19):2090-2091. doi:10.1001/jama.2009.1640

In Reply: We thank Dr Smoljanovic and colleagues for their comments regarding complications associated with BMP usage. As we noted in our article, the available data did not allow us to address the correlation between dosage of BMP and complication rate. We agree that additional work is needed to clarify the short-term and long-term complications associated with different dosages of BMP.